Elicio Therapeutics's market cap is currently $164.20M. The company's EPS TTM is $-0.66; its P/E ratio is ―; Elicio Therapeutics is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $-0.55. See an overview of income statement, balance sheet, and cash flow financials.
